Dissecting Piramal’s Damages Award In Sensipar Case
Executive Summary
A legal expert details how Piramal Healthcare could turn the tables and secure damages in the litigation pertaining to its generic version of Amgen's Sensipar, a case which saw multiple at-risk launches.